InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,702.50
(
-0.82%
)
Post# of 2221
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: None

Thursday, 01/28/2021 7:17:28 PM

Thursday, January 28, 2021 7:17:28 PM

Post# of 2221
Just noticed this story from Jan. 19th that the DOD has hired CRO Pharm-Olam ($36 million) to test Humira against Covid 19 as an inflammation fighter. In the Akers Biosiences Nov. 18 business report, MyMD Chief Scientific Officer, Dr. Adam Kaplan made it pretty clear that MYMD-1 was triple threat superior to Humira in inflammation reduction, anti-depression, and maintenance of immune system.

https://ih.advfn.com/stock-market/stock-news/84120896/us-department-of-defense-selects-pharm-olam-as-cro

Comments welcomed.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!